[Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?].
Maslov
L N
LN
Lishmanov
Iu B
IuB
Naumova
A V
AV
Lasukova
T V
TV
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000201:enzymology / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D003402:Creatine Kinase / Q000378:metabolism; D066298:In Vitro Techniques; D015428:Myocardial Reperfusion Injury / Q000150:complications; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009270:Naloxone / Q000494:pharmacology; D010936:Plant Extracts / Q000494:pharmacology; D010946:Plants, Medicinal / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000037:antagonists & inhibitors / Q000378:metabolism*
D000889:Anti-Arrhythmia Agents; D010936:Plant Extracts; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D009270:Naloxone; D003402:Creatine Kinase